Compare Steady Safe Tbk (SAFE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Steady Safe Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Steady Safe Tbk trades at Rp875 (market cap 574.85B, 1.59M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Steady Safe Tbk is far larger — about 5.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SAFE | SCPI | |
|---|---|---|
Market Cap | 574.85B | 104.4B |
Volume | 1.59M | — |
Lot | 15.86K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Steady Safe Tbk
PT Steady Safe is a major transportation company serving Indonesia and primarily the capital, Jakarta. It was established in 1971 under the name “PT Tanda Widjaja Sakti”. In December 1993, in preparation for the public offering of its shares, the company changed its name to PT Steady Safe. The start-up with a license to operate 150 vehicles as taxis for Jakarta has today become a premier mass transportation company. Steady Safe has introduced the Jakarta’s first privately managed air-conditioned buses. At present, the company operates thirteen Pool and workshops in the Greater Jakarta Area for the logistical and technical support of its taxi and bus fleets. Steady Safe is listed in Jakarta Stock Exchange and the Surabaya Stock Exchange with 213,839,600 shares traded under the stock code SAFE.
Read more on SAFE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
